Long-term safety and efficacy of 13.3mg/24h rivastigmine patch in severe Alzheimer's disease: ACTivities of daily living and cognitION (ACTION) study.

Saved in:
Bibliographic Details
Title: Long-term safety and efficacy of 13.3mg/24h rivastigmine patch in severe Alzheimer's disease: ACTivities of daily living and cognitION (ACTION) study.
Authors: Farlow, M.1, Grossberg, G.2, Sadowsky, C.3, Meng, X.4, Somgyi, M.4
Source: Journal of the Neurological Sciences. Oct2013, Vol. 333, pe339-e339. 1p.
Database: Academic Search Ultimate
Description
ISSN:0022510X
DOI:10.1016/j.jns.2013.07.1252